Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTB-015: Biomarker-Guided CNI Substitution In Kidney Transplantation
NCT05917522Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2023
- Primary completion
- Jul 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in kidney transplantation, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2023; status: recruiting.
02
Drugs
abatacept
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT05917522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05917522.